CASSIPHARMA
Timeline
34 events since 2002Board
Capital
Filings
Financial
Establishments
20052010201520202025
The 2026 accounts are due by 31-01-2027.
2026
Annual accounts 2025 filed PDFabbreviated format · 1 day before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0477736777
Back to profit net €8,177 The net result is €8,177, after 2 loss-making years.
Annual accounts 2024 filed PDFabbreviated format · on the deadline day
2024
Annual accounts 2023 filed PDFabbreviated format · on the deadline day
2023
Weakest financial year net -€71,001 The net result drops to -€71,001, the lowest from 2007 to 2025. It recovers the following year.
Demerger: CASSIPHARMA splits off to DOMICAPHARMA changes role from manager to director · acts as permanent representative · “nieuw voorwerp” (deed in Dutch) · General meeting of 30-01-20237 points ▸
- General meeting, 30-01-2023
- Purpose change, “nieuw voorwerp” (deed in Dutch)
- 100 shares
- Director resignation, (manager)
- Director appointment, (director (not named in the articles))
- Permanent representative,
- Registered office clause, Koning Boudewijnstraat 25, 9000 Gent
- The deed holds 4 more points.
Annual accounts 2022 filed PDFabbreviated format · 12 days before the deadline
2022
Demerger proposal: CASSIPHARMA splits off to DOMICAPHARMA appointed as statutory auditor · and act as permanent representatives7 points ▸
- Accounting effect, 01-07-2022
- Auditor appointment,
- Permanent representative,
- Registered office clause, Koning Boudewijnstraat 25, 9000 Gent
- Capital, €18,600, 100 shares
- Board composition, (director)
- Permanent representative,
- The deed holds 27 more points.
Annual accounts 2021 filed PDFabbreviated format · on the deadline day
2021
Annual accounts 2020 filed PDFabbreviated format · 9 days before the deadline
2020
Annual accounts 2019 filed PDFabbreviated format · 2 days before the deadline
2018
Annual accounts 2018 filed PDFabbreviated format · 51 days before the deadline
Annual accounts 2017 filed PDFabbreviated format · 20 days before the deadline
2016
Annual accounts 2016 filed PDFabbreviated format · 42 days before the deadline
2015
Annual accounts 2015 filed PDFabbreviated format · 54 days before the deadline
2014
Annual accounts 2014 filed PDFabbreviated format · 44 days before the deadline
New manager appointed, resigned · acts as permanent representative · Director discharge: · General meeting of 27-01-20145 points ▸
- General meeting, 27-01-2014
- Director resignation, (statutory manager)
- Director discharge,
- Director appointment, (manager (not named in the articles))
- Permanent representative,
- The deed holds 2 more points.
2013
Annual accounts 2013 filed PDFabbreviated format · 78 days before the deadline
Highest result from 2007 to 2025 net €139,530 ▲1.1% The operating result of €195,133 and the net result of €139,530 are both a record.
Equity above €1m equity €1.0m ▲15.4% With a profit in every financial year since 2007, equity grows to €1.0m.
Annual accounts 2012 filed PDFabbreviated format · 3 days before the deadline
2012
Annual accounts 2011 filed PDFabbreviated format · 9 days late
2011
Annual accounts 2010 filed PDFabbreviated format · 17 days late
2010
Annual accounts 2009 filed PDFabbreviated format · 18 days before the deadline
2009
Equity above €500,000 equity €551,110 ▲16.9% With a profit in every financial year since 2007, equity grows to €551,110.
Annual accounts 2008 filed PDFabbreviated format · 13 days late
2008
Annual accounts 2007 filed PDFabbreviated format · 15 days late
2006
Annual accounts 2006 filed PDFabbreviated format · 56 days before the deadline
2005
Annual accounts 2005 filed PDFabbreviated format
2004
Annual accounts 2004 filed PDFabbreviated format
2003
Annual accounts 2003 filed PDFabbreviated format
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank